These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9759782)

  • 21. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients.
    Piperno A; Arosio C; Fargion S; Roetto A; Nicoli C; Girelli D; Sbaiz L; Gasparini P; Boari G; Sampietro M; Camaschella C
    Hepatology; 1996 Jul; 24(1):43-6. PubMed ID: 8707280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for hereditary haemochromatosis should be implemented now.
    Allen K; Williamson R
    BMJ; 2000 Jan; 320(7228):183-4. PubMed ID: 10634748
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening for haemochromatosis--producing or preventing illness?
    Adams PC
    Lancet; 2005 Jul 23-29; 366(9482):269-71. PubMed ID: 16039315
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.
    Ellervik C; Mandrup-Poulsen T; Nordestgaard BG; Larsen LE; Appleyard M; Frandsen M; Petersen P; Schlichting P; Saermark T; Tybjaerg-Hansen A; Birgens H
    Lancet; 2001 Oct; 358(9291):1405-9. PubMed ID: 11705485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of screening for hereditary hemochromatosis.
    Phatak PD; Guzman G; Woll JE; Robeson A; Phelps CE
    Arch Intern Med; 1994 Apr; 154(7):769-76. PubMed ID: 8147681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for diabetes in general practice. Population screening for diabetes is cost effective.
    Higson N
    BMJ; 2002 Feb; 324(7334):426. PubMed ID: 11855395
    [No Abstract]   [Full Text] [Related]  

  • 27. [Screening in primary health care. Presentation of a case of familial hemochromatosis].
    Ibáñez Estella JA; Sánchez Ibáñez A; Rubio Montañés ML; Malumbres Juarros P; Izquierdo Clemente C
    An Med Interna; 1992 Oct; 9(10):516. PubMed ID: 1420767
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.
    Adams PC; Valberg LS
    Am J Gastroenterol; 1999 Jun; 94(6):1593-600. PubMed ID: 10364030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group.
    Porto G; Vicente C; Fraga J; da Silva BM; de Sousa M
    J Lab Clin Med; 1992 Mar; 119(3):295-305. PubMed ID: 1541878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of genetic haemochromatosis in diabetic patients.
    Lancet; 1989 Oct; 2(8668):925. PubMed ID: 2571849
    [No Abstract]   [Full Text] [Related]  

  • 31. You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation.
    Piippo K; Louhija J; Tilvis R; Kontula K
    Eur J Clin Invest; 2003 Sep; 33(9):830-1. PubMed ID: 12925044
    [No Abstract]   [Full Text] [Related]  

  • 32. Should we genetically test everyone for haemochromatosis?
    Allen K; Williamson R
    J Med Ethics; 1999 Apr; 25(2):209-14. PubMed ID: 10226930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for type 2 diabetes.
    Kessel E
    JAMA; 1999 Jun; 281(21):1987-8. PubMed ID: 10359383
    [No Abstract]   [Full Text] [Related]  

  • 34. Deaths attributed to haemochromatosis are rare in Britain.
    Willis G; Fellows IW; Wimperis JZ
    BMJ; 2000 Apr; 320(7242):1146. PubMed ID: 10775237
    [No Abstract]   [Full Text] [Related]  

  • 35. [Digestive disorders: improving the accuracy and safety of tests].
    Bonnaud G
    Presse Med; 1998 May; 27(18):869-70. PubMed ID: 9767877
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemochromatosis: where are all the patients?
    Ho GT; Stanley AJ
    Scott Med J; 2001 Aug; 46(4):99-100. PubMed ID: 11676045
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemochromatosis and genetics.
    Janković GM; Colović MD; Bogdanović AD; Janković SJ; Mihel A; Trpinac DP; Janosević S
    Am J Hematol; 1994 Sep; 47(1):60-1. PubMed ID: 8042619
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for type 2 diabetes.
    Goyder E; Irwig L
    JAMA; 1999 Jun; 281(21):1986-7; author reply 1987-8. PubMed ID: 10359382
    [No Abstract]   [Full Text] [Related]  

  • 39. Conflicting results on variation in the IGFI gene highlight methodological considerations in the design of genetic association studies.
    Frayling TM; Hattersley AT; Smith GD; Ben-Shlomo Y
    Diabetologia; 2002 Nov; 45(11):1605-6. PubMed ID: 12498159
    [No Abstract]   [Full Text] [Related]  

  • 40. Idiopathic haemochromatosis--a family study.
    MORGAN EH
    Australas Ann Med; 1961 May; 10():114-20. PubMed ID: 13772570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.